{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:45:07Z","timestamp":1762375507338,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["SBO50151\/SBO060819"],"award-info":[{"award-number":["SBO50151\/SBO060819"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.expneurol.2011.03.014","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T06:14:22Z","timestamp":1302329662000},"page":"440-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease"],"prefix":"10.1016","volume":"229","author":[{"given":"C.","family":"Casteels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dresselaers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Himmelreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 6","key":"10.1016\/j.expneurol.2011.03.014_bb0005","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0010","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.tpj.6500301","article-title":"Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)","volume":"5","author":"Barrero","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0925-4439(98)00042-8","article-title":"Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats","volume":"1407","author":"Berrendero","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington's disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0035","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1073\/pnas.0703472104","article-title":"[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor","volume":"104","author":"Burns","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2009.12.026","article-title":"In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease","volume":"1316","author":"Casteels","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0055","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1007\/s00259-010-1574-2","article-title":"Type 1 cannabinoid receptor mapping with [(18)F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism","volume":"37","author":"Casteels","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0060","first-page":"1858","article-title":"Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain","volume":"47","author":"Casteels","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0085","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.neuropharm.2008.02.018","article-title":"An in vivo [(18)F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam","volume":"54","author":"Goffin","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0163-7258(02)00250-4","article-title":"From cannabis to cannabinergics: new therapeutic opportunities","volume":"95","author":"Goutopoulos","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0095","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.37.9.1441","article-title":"The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease","volume":"37","author":"Hayden","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0100","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-4328(96)00043-5","article-title":"Effects of amphetamine, morphine and dizocilpine (MK-801) on spontaneous alternation in the 8-arm radial maze","volume":"81","author":"Holter","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0115","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.physbeh.2007.07.018","article-title":"Strain and locomotor speed affect over-ground locomotion in intact rats","volume":"92","author":"Koopmans","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0130","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0140","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1109\/42.563664","article-title":"Multimodality image registration by maximization of mutual information","volume":"16","author":"Maes","year":"1997","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0155","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1242\/jeb.02208","article-title":"Neuron-glia metabolic coupling and plasticity","volume":"209","author":"Magistretti","year":"2006","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0160","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0170","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0175","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/01.WCB.0000090623.86921.47","article-title":"Determination of kinetic rate constants for 2-[18F]fluoro-2-deoxy-d-glucose and partition coefficient of water in conscious macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique","volume":"23","author":"Noda","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0185","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0306-4522(97)00552-6","article-title":"Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats","volume":"84","author":"Romero","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0190","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00259-009-1340-5","article-title":"Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain","volume":"37","author":"Sanabria-Bohorquez","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1139\/jpn.0705","article-title":"Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?","volume":"32","author":"Solowij","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0200","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0205","first-page":"1398","article-title":"Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography","volume":"45","author":"Toyama","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington's in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0220","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/nimg.2001.1047","article-title":"Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design","volume":"16","author":"Van Laere","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0230","first-page":"11","article-title":"Automated quantitative gait analysis in animal models of movement disorders","volume":"9","author":"Vandeputte","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington's disease","volume":"12","author":"von Horsten","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0245","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neurobiolaging.2005.05.020","article-title":"Effects of age on volumes of cortex, white matter and subcortical structures","volume":"26","author":"Walhovd","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2011.03.014_bb0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2004.12.011","article-title":"Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6\/2 mouse model of Huntington's disease","volume":"231","author":"Wang","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.physbeh.2008.10.020","article-title":"Age, experience and genetic background influence treadmill walking in mice","volume":"96","author":"Wooley","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2011.03.014_bb0260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/archneur.1987.00520150010010","article-title":"Normal caudate glucose metabolism in persons at risk for Huntington's disease","volume":"44","author":"Young","year":"1987","journal-title":"Arch. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:46:28Z","timestamp":1762148788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0014488611000987"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.03.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"type":"print","value":"0014-4886"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}